drugset / Trial / NCT00447551
Canadian Aesthetic Experience With Sculptra Therapy
NaSingle-groupOpen-labelTreatment
Summary
Primary objective To evaluate the degree of correction achievable with Sculptra for nasolabial folds, mid- and lower facial volume loss, jawline laxity and other signs of facial ageing. To document the types and incidence of device-related adverse events with Sculptra.
Timeline
- Start
- 2007-01
- Primary completion
- 2008-04
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Poly-L-Lactic Acid | Small molecule | — | Other |